VANCOUVER, British Columbia, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “AGN Pharma”) (CSE: AGN) (FRANKFURT: AGW0 ...
VANCOUVER, British Columbia, April 24, 2024 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “AGN Pharma ...
LONDON, Sept. 19, 2022 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “Company” or “Small Pharma”), a biotechnology company focused on short-acting psychedelic-assisted ...
DMT-DRIFTx partnership seeks to develop a safe and sustainable mobility landscape in Abu Dhabi and beyond DRIFTx will take place from April 25-26 at Yas Marina, reinforcing Abu Dhabi’s emergence as a ...
Advanced brain imaging in a study from a team of U.K.-based scientists shows how dimethyltryptamine (DMT) alters perception of reality by changing communication and connectivity. According to a March ...
- Newly issued patents include protection for injectable formulations and synthesis methods for the preparation of dimethyltryptamine (“DMT”) and deuterated DMT (“dDMT”) - - Cybin’s patent portfolio ...
VANCOUVER, British Columbia, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company ...
The MarketWatch News Department was not involved in the creation of this content. "Driven by urgent unmet needs and scientific advances, the Alzheimer's Disease DMT market is poised for rapid growth ...
VANCOUVER, British Columbia, Sept. 12, 2022 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF) a clinical stage pharmaceutical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback